Edition:
United States

Atossa Genetics Inc (ATOS.OQ)

ATOS.OQ on NASDAQ Stock Exchange Capital Market

1.21USD
22 Mar 2017
Change (% chg)

$-0.08 (-6.20%)
Prev Close
$1.29
Open
$1.28
Day's High
$1.28
Day's Low
$1.20
Volume
13,974
Avg. Vol
19,064
52-wk High
$6.30
52-wk Low
$1.20

ATOS.OQ

Chart for ATOS.OQ

About

Atossa Genetics Inc. is a clinical-stage pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The Company's leading program uses its intraductal microcatheters, which deliver pharmaceuticals through the breast ducts. It has... (more)
No analyst recommendations are available for ATOS.OQ.

Overall

Beta: 1.38
Market Cap(Mil.): $4.89
Shares Outstanding(Mil.): 3.79
Dividend: --
Yield (%): --

Financials

  ATOS.OQ Industry Sector
P/E (TTM): -- 47.39 30.07
EPS (TTM): -2.81 -- --
ROI: -88.87 7.82 13.05
ROE: -88.91 11.79 14.20

BRIEF-Atossa Genetics amends qtrly loss to $0.04/shr in Form 10-Q amendment for qtr ended June 30, 2016

* Atossa Genetics Inc - amendment no. 1 to quarterly report on Form 10-Q amends company's quarterly report on Form 10-Q for quarter ended June 30, 2016

Mar 21 2017

BRIEF-Atossa Genetics reports Q3 earnings per share from continuing operations $0.07

* Quarterly earnings per share from continuing operations $0.07

Nov 14 2016

BRIEF-Atossa Genetics to provide company update and discuss third quarter 2016 financial results

* Atossa Genetics to provide company update and discuss third quarter 2016 financial results on conference call on Monday, November 14, 2016 Source text for Eikon: Further company coverage:

Nov 10 2016

More From Around the Web

Earnings vs. Estimates